Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
27,94 USD | -3,49% | -19,13% | -50,07% |
18/04 | 10X GENOMICS, INC. : Deutsche Bank Securities bevestigt koopadvies | ZM |
26/03 | 10x Genomics, Inc. brengt Visium HD Spatial Gene Expression Assay commercieel op de markt | CI |
Omzet 2024 * | 678 mln. 636 mln. | Omzet 2025 * | 790 mln. 741 mln. | Marktkapitalisatie | 3,33 mld. 3,13 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -188 mln. -176 mln. | Nettowinst (verlies) 2025 * | -114 mln. -107 mln. | EV/omzet 2024 * | 4,43 x |
Nettoliquiditeiten 2024 * | 324 mln. 304 mln. | Nettoliquiditeiten 2025 * | 366 mln. 344 mln. | EV/omzet 2025 * | 3,75 x |
K/w-verhouding 2024 * |
-17,7
x | K/w-verhouding 2025 * |
-30,3
x | Werknemers | 1.259 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 85,5% |
Recentste transcriptie over 10x Genomics, Inc.
1 dag | -3,49% | ||
1 week | -19,13% | ||
Lopende maand | -25,55% | ||
1 maand | -25,35% | ||
3 maanden | -33,16% | ||
6 maanden | -29,68% | ||
Lopend jaar | -50,07% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Serge Saxonov
FOU | Founder | 47 | 02-07-12 |
Ben Hindson
FOU | Founder | 49 | 02-07-12 |
Justin McAnear
DFI | Director of Finance/CFO | 49 | 01-10-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Stuelpnagel
CHM | Chairman | 66 | 01-08-13 |
Kim Popovits
BRD | Director/Board Member | 65 | 26-03-20 |
Mathai Mammen
BRD | Director/Board Member | 57 | 23-08-17 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 27,94 | -3,49% | 2 078 465 |
18-04-24 | 28,95 | -0,72% | 2 956 118 |
17-04-24 | 29,16 | -5,32% | 3 063 043 |
16-04-24 | 30,8 | -6,27% | 2 278 394 |
15-04-24 | 32,86 | -4,89% | 1 309 105 |
uitgestelde koers Nasdaq, 19 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-50,07% | 3,45 mld. | |
-1,04% | 12,47 mld. | |
-17,29% | 6,99 mld. | |
-2,21% | 5,1 mld. | |
+2,92% | 4,27 mld. | |
-4,79% | 4,27 mld. | |
+7,65% | 2,61 mld. | |
-15,92% | 2,08 mld. | |
-3,34% | 1,67 mld. | |
-13,66% | 1,48 mld. |